Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DRI | MCD |
|---|---|---|
| Price | $194.64 | $231.55 |
| Change today | ▲ 0.72% | ▲ 0.26% |
| Market cap | $22.10B | $163.85B |
| Return, 3 months | -2.9% | -13.4% |
| Return, year to date | +8.2% | -22.8% |
| Return, 1 year | +4.4% | -21.0% |
| P/E (TTM) | 19.0 | 18.8 |
| P/B | 10.7 | -160.1 |
| P/E percentile vs own 5y | 30th | 0th |
| Dividend yield | 3.14% | 3.17% |
| Revenue growth (YoY, latest qtr) | +5.1% | +3.8% |
| Net profit growth (YoY) | -9.5% | +4.8% |
| Gross margin | 21.7% | 57.4% |
| Operating margin | 12.2% | 45.7% |
| Net margin | 8.8% | 31.7% |
| Return on equity | 55.1% | – |
| Analyst target vs. price | +21.7% | +28.7% |
| Analyst buy share | 74% | 58% |
| RSI (14) | 33 | 22 |
| 30-day volatility | 30.9% | 20.3% |
| Max drawdown, 1 year | -15.1% | -31.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
